Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
1180.00
Change Change %
3.40 0.29%

Updated:17 Jul, 2019, 11:44 AM IST

BSE
1179.00
Change Change %
4.20 0.36%

Updated:17 Jul, 2019, 11:49 AM IST

Glaxosmithkline Phar's Financial Summary

View last 5 years Financial Summary

Parameter MAR'19
(₹ Cr.)
MAR'18
(₹ Cr.)
Change %
Net Profit Before Taxes 658.82 523.79 25.78%
Adjustments for Expenses & Provisions -30.52 -11.15 -173.78%
Adjustments for Liabilities & Assets -7.58 163.69 -104.63%
Cash Flow from operating activities 401.07 474.77 -15.52%
Cash Flow from investing activities -144.33 -107.01 -34.87%
Cash Flow from financing activities -358.36 -306.63 -16.87%
Effect of exchange fluctuation on translation reserve 0.00 0.00 0.00%
Net increase/(decrease) in cash and cash equivalents -101.62 61.12 -266.25%
Opening Cash & Cash Equivalents 199.40 138.27 44.20%
Cash & Cash Equivalent on Amalgamation / Take over / Merger 0.00 0.00 0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations 0.00 0.00 0.00%
Translation adjustment on reserves / op cash balalces frgn subsidiaries 0.00 0.00 0.00%
Effect of Foreign Exchange Fluctuations 0.00 0.00 0.00%
Closing Cash & Cash Equivalent 97.78 199.40 -50.96%
Top